KardiaAI
Overview
Operating as a Software as a Medical Device (SaMD), it processes various physiological parameters from 30-second ECGs. The capabilities of KardiaAI are provided as an Application Program Interface (API) library, allowing it to be integrated into other compatible ECG devices and mobile applications.
The tool performs essential functions such as ECG noise filtering and the detection of noisy ECGs. Its core analytical strength lies in identifying a range of cardiac conditions, including normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia. Furthermore, KardiaAI can detect more nuanced conditions like Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE), providing comprehensive heart rhythm analysis for healthcare professionals and patients.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered ECG analysis library
- Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm
- Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs)
- Detection of Sinus Rhythm with Wide QRS
- Detection of Sinus Rhythm with Supraventricular Ectopy (SVE)
- ECG noise filtering and noisy ECG detection
- API library for integration into other ECG devices and software
- Medical-grade accuracy for heart rhythm data
- Supports 6-lead and 12-lead ECG analysis (via integrated devices)
- Remote heart rhythm monitoring capabilities
Use Cases
- Remote heart rhythm monitoring for patients
- Early detection and management of atrial fibrillation and other arrhythmias
- Supporting clinical research and trials
- In-office ECG solutions for rapid assessment (via KardiaStation)
- Remote patient management for healthcare professionals (via KardiaPro)
- Disease and safety monitoring in biopharma
What Physicians Need to Know
Kardia 12L offers a portable 12-lead ECG solution, lighter than a smartphone, for healthcare professionals. The platform provides deep, real-time analysis of heart rhythm data and integrates into existing workflows. Consider utilizing the two-week trial for eligible U.S. HCPs for Kardia 12L.
AliveCor offers API & SDK Solutions for data integration. Their technology is designed to seamlessly connect with existing workflows for healthcare professionals and provides an enterprise platform for health systems to remotely track patient heart rhythm data.
Details
| Category | Cardiology AI |
| Pricing | Subscription-based for advanced features and services. |
| Deployment | Mobile app, cloud-based. |
| Mobile App | 1 |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2020-11-12 | K201985 510(k) | KardiaAI |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate KardiaAI
Videos
Product demos, reviews, and walkthroughs for KardiaAI.
How to record a 12-lead ECG with Kardia 12L (1:33)
Kardia by AliveCor
Frequently Asked Questions
Compare KardiaAI
VS
VS
VS
VS
Investors who backed KardiaAI
Funded through the company that built this tool.











